Please Note: This trial is no longer enrolling new participants
A Phase II/III Study of N-803 (ALT-803) plus Pembrolizumab versus Standard of Care in Participants with Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy (Lung-MAP Non-Match Sub-Study)
| Protocol No. | S1800D | Scope | National |
|---|---|---|---|
| Principal Investigator | Rohan Maniar | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II/III |
